CH585556A5 - - Google Patents
Info
- Publication number
- CH585556A5 CH585556A5 CH429574A CH429574A CH585556A5 CH 585556 A5 CH585556 A5 CH 585556A5 CH 429574 A CH429574 A CH 429574A CH 429574 A CH429574 A CH 429574A CH 585556 A5 CH585556 A5 CH 585556A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1492073A GB1468172A (en) | 1973-03-28 | 1973-03-28 | Oral drug preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
CH585556A5 true CH585556A5 (nl) | 1977-03-15 |
Family
ID=10049906
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH429574A CH585556A5 (nl) | 1973-03-28 | 1974-03-26 |
Country Status (14)
Country | Link |
---|---|
US (1) | US3917813A (nl) |
JP (1) | JPS5414649B2 (nl) |
BE (1) | BE812909A (nl) |
CA (1) | CA1029658A (nl) |
CH (1) | CH585556A5 (nl) |
DE (1) | DE2414868C3 (nl) |
FI (1) | FI58069C (nl) |
FR (1) | FR2223047B1 (nl) |
GB (1) | GB1468172A (nl) |
NL (1) | NL182369C (nl) |
NO (1) | NO142155C (nl) |
SE (1) | SE413578B (nl) |
SU (1) | SU665778A3 (nl) |
ZA (1) | ZA741963B (nl) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
AR216922A1 (es) * | 1976-11-11 | 1980-02-15 | Merck Patent Gmbh | Procedimiento para la fabricacion de un medio quirurgico |
FR2377196A1 (fr) * | 1977-01-13 | 1978-08-11 | Lipha | Composition medicamenteuse a usage oral |
US4218433A (en) * | 1977-03-03 | 1980-08-19 | Nippon Kayaku Kabushiki Kaisha | Constant-rate eluting tablet and method of producing same |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4196187A (en) * | 1977-09-02 | 1980-04-01 | Eastman Kodak Company | Rumen-stable pellets |
US4181709A (en) * | 1977-09-02 | 1980-01-01 | Eastman Kodak Company | Rumen-stable pellets |
US4181708A (en) * | 1977-09-02 | 1980-01-01 | Eastman Kodak Company | Rumen-stable pellets |
US4177255A (en) * | 1977-09-02 | 1979-12-04 | Eastman Kodak Company | Rumen-stable pellets |
US4153677A (en) * | 1978-05-18 | 1979-05-08 | Sterling Drug Inc. | Controlled-release composition |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
FR2470600A2 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
DE3000979A1 (de) | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
DE3126703A1 (de) | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
FR2525474A1 (fr) * | 1982-04-26 | 1983-10-28 | Roussel Uclaf | Nouvelle forme pharmaceutique orale de clometacine |
WO1984000004A1 (en) * | 1982-06-14 | 1984-01-05 | Key Pharma | Sustained release aspirin |
US4508702A (en) * | 1982-06-14 | 1985-04-02 | Key Pharmaceuticals, Inc. | Sustained release aspirin |
WO1984000295A1 (en) * | 1982-07-09 | 1984-02-02 | Key Pharma | Sustained release quinidine dosage form |
US4634587A (en) * | 1982-07-09 | 1987-01-06 | Key Pharmaceuticals, Inc. | Sustained release quinidine dosage form |
DK152744C (da) * | 1982-08-13 | 1988-10-31 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat |
DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
FR2532177A1 (fr) * | 1982-08-30 | 1984-03-02 | Being Well Products Inc | Complement nutritionnel a zones de liberation determinees et son procede de fabrication |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4773907A (en) * | 1982-12-20 | 1988-09-27 | Alza Corporation | Primary delivery system comprising secondary dosage form |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4555399A (en) * | 1983-11-18 | 1985-11-26 | Key Pharmaceuticals, Inc. | Aspirin tablet |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
DE3586600T2 (de) | 1984-02-10 | 1993-02-18 | Benzon Pharma As | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. |
US4618487A (en) * | 1984-07-06 | 1986-10-21 | Alza Corporation | Device for administering calcium ascorbate |
US4867984A (en) * | 1984-11-06 | 1989-09-19 | Nagin K. Patel | Drug in bead form and process for preparing same |
GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
GB8616669D0 (en) * | 1986-07-09 | 1986-08-13 | Merk Sharpe & Dohme Ltd | Pharmaceutical compositions |
SE8701479L (sv) * | 1987-04-09 | 1988-10-10 | Carbomatrix Ab | Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav |
IE60311B1 (en) * | 1987-09-24 | 1994-06-29 | American Home Prod | Sustained release etodolac |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
JPH03145418A (ja) * | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5149775A (en) * | 1991-01-25 | 1992-09-22 | Eastman Kodak Company | Method for purifying high molecular weight vinylpyridine/styrene polymers from solution |
DK0585355T3 (da) * | 1991-05-20 | 1995-06-06 | Tanabe Seiyaku Co | Flerlagspræparat med reguleret frigivelse |
US5518737A (en) * | 1991-10-16 | 1996-05-21 | Orion-Yhtyma Oy | Peroral drug delivery system |
WO1998041210A1 (fr) * | 1997-03-14 | 1998-09-24 | Toray Industries, Inc. | Preparation de derive de prostaglandine i a liberation prolongee |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
US20030175349A1 (en) * | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
EP2363117B1 (en) * | 2006-01-27 | 2015-08-19 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids |
EP1976492B8 (en) * | 2006-01-27 | 2018-07-04 | Adare Pharmaceuticals, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2971889A (en) * | 1958-03-18 | 1961-02-14 | Smith Kline French Lab | Press coated enteric tablets and process for preparing them |
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
US3341416A (en) * | 1963-12-11 | 1967-09-12 | Ncr Co | Encapsulation of aspirin in ethylcellulose and its product |
US3584113A (en) * | 1967-08-31 | 1971-06-08 | Eisai Co Ltd | Process for the production of medical preparations having sustained release of therapeutical effect |
BE744162A (fr) * | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3629392A (en) * | 1969-08-15 | 1971-12-21 | Gilbert S Banker | Entrapment compositions and processes |
US3608063A (en) * | 1969-08-15 | 1971-09-21 | Gilbert S Banker | Molecular drug entrapment process and compositions |
US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
DE2031871C3 (de) * | 1970-06-27 | 1974-06-27 | Roehm Gmbh, 6100 Darmstadt | Überzugsmasse für Arzneiformen |
-
1973
- 1973-03-28 GB GB1492073A patent/GB1468172A/en not_active Expired
-
1974
- 1974-03-20 US US453032A patent/US3917813A/en not_active Expired - Lifetime
- 1974-03-26 CH CH429574A patent/CH585556A5/xx not_active IP Right Cessation
- 1974-03-26 JP JP3383574A patent/JPS5414649B2/ja not_active Expired
- 1974-03-27 FR FR7410617A patent/FR2223047B1/fr not_active Expired
- 1974-03-27 NL NLAANVRAGE7404134,A patent/NL182369C/nl not_active IP Right Cessation
- 1974-03-27 ZA ZA00741963A patent/ZA741963B/xx unknown
- 1974-03-27 DE DE2414868A patent/DE2414868C3/de not_active Expired
- 1974-03-27 NO NO741084A patent/NO142155C/no unknown
- 1974-03-27 BE BE142515A patent/BE812909A/xx not_active IP Right Cessation
- 1974-03-27 SE SE7404099A patent/SE413578B/xx not_active IP Right Cessation
- 1974-03-27 CA CA196,186A patent/CA1029658A/en not_active Expired
- 1974-03-27 FI FI932/74A patent/FI58069C/fi active
- 1974-03-27 SU SU742015169A patent/SU665778A3/ru active
Also Published As
Publication number | Publication date |
---|---|
NO142155B (no) | 1980-03-31 |
BE812909A (fr) | 1974-07-15 |
FR2223047A1 (nl) | 1974-10-25 |
FI58069B (fi) | 1980-08-29 |
JPS5414649B2 (nl) | 1979-06-08 |
NL182369C (nl) | 1988-03-01 |
NL7404134A (nl) | 1974-10-01 |
US3917813A (en) | 1975-11-04 |
NL182369B (nl) | 1987-10-01 |
FI58069C (fi) | 1980-12-10 |
AU6726974A (en) | 1975-10-02 |
SU665778A3 (ru) | 1979-05-30 |
JPS5029729A (nl) | 1975-03-25 |
DE2414868B2 (de) | 1980-04-30 |
ZA741963B (en) | 1975-03-26 |
CA1029658A (en) | 1978-04-18 |
DE2414868A1 (de) | 1974-10-10 |
NO741084L (no) | 1974-10-01 |
NO142155C (no) | 1980-07-09 |
GB1468172A (en) | 1977-03-23 |
SE413578B (sv) | 1980-06-09 |
DE2414868C3 (de) | 1987-07-09 |
FR2223047B1 (nl) | 1978-08-18 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |